Twist Bioscience Corporation (TWST) Financial Statements (2024 and earlier)

Company Profile

Business Address 681 GATEWAY BLVD.
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End September 30
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
12/31/2022
MRQ
9/30/2022
9/30/2021
9/30/2020
9/30/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:438,710504,968477,863290,002138,107
Cash and cash equivalents316,681378,687465,82993,66746,735
Short-term investments122,029126,28112,034196,33591,372
Other undisclosed cash, cash equivalents, and short-term investments     
Restricted cash and investments     84
Receivables44,43740,29428,54926,37612,104
Inventory, net of allowances, customer advances and progress billings44,59739,30731,80012,2897,330
Inventory44,59739,30731,80012,2897,330
Other undisclosed current assets14,11511,9148,2836,2032,510
Total current assets:541,859596,483546,495334,870160,135
Noncurrent Assets
Operating lease, right-of-use asset73,75774,94861,58033,699 
Property, plant and equipment144,850139,44144,12225,46620,835
Intangible assets, net (including goodwill)144,172145,54940,6961,4451,646
Goodwill85,81185,81122,4341,1381,138
Intangible assets, net (excluding goodwill)58,36159,73818,262307508
Restricted cash and investments2,4101,5721,530579579
Other noncurrent assets2,9223,3857,6742,8233,799
Total noncurrent assets:368,111364,895155,60264,01226,859
TOTAL ASSETS:909,970961,378702,097398,882186,994
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities53,78857,28443,66423,67626,204
Employee-related liabilities23,27727,02322,32714,94510,479
Accounts payable20,11320,09214,9004,8309,760
Accrued liabilities10,39810,1696,4373,9015,965
Debt   1,5523,3333,333
Other liabilities15,82219,7379,6232,611817
Other undisclosed current liabilities14,22713,6428,2136,409 
Total current liabilities:83,83790,66363,05236,02930,354
Noncurrent Liabilities
Long-term debt and lease obligation   53,15626,2404,400
Long-term debt, excluding current maturities    1,4034,400
Liabilities, other than long-term debt79,80881,3305,068351158
Other liabilities60605,068351158
Operating lease, liability79,74881,27053,15624,837 
Total noncurrent liabilities:79,80881,33058,22426,5914,558
Total liabilities:163,645171,993121,27662,62034,912
Equity
Equity, attributable to parent746,325789,385580,821336,262152,082
Additional paid in capital1,617,1741,619,6441,190,828794,630470,425
Accumulated other comprehensive income (loss)(609)(1,843)54687181
Accumulated deficit(870,240)(828,416)(610,553)(458,455)(318,524)
Total equity:746,325789,385580,821336,262152,082
TOTAL LIABILITIES AND EQUITY:909,970961,378702,097398,882186,994

Income Statement (P&L) ($ in thousands)

9/30/2023
12/31/2022
TTM
9/30/2022
9/30/2021
9/30/2020
9/30/2019
Revenues215,789203,565132,33390,10054,385
Cost of revenue(121,716)(119,330)(80,620)(61,406)(47,426)
Gross profit:94,07384,23551,71328,6946,959
Operating expenses(333,093)(333,256)(204,973)(168,773)(115,809)
Other undisclosed operating income (loss)15,55414,245534  
Operating loss:(223,466)(234,776)(152,726)(140,079)(108,850)
Nonoperating income (expense)9,4686,582(935)1,3172,767
Investment income, nonoperating10,5567,6694351,4993,032
Other nonoperating expense(1,088)(1,087)(1,370)(182)(265)
Interest and debt expense(56)(80)(367)(787)(1,294)
Loss from continuing operations before income taxes:(214,054)(228,274)(154,028)(139,549)(107,377)
Income tax expense (benefit)(70)10,4111,930(382)(292)
Loss from continuing operations:(214,124)(217,863)(152,098)(139,931)(107,669)
Loss before gain (loss) on sale of properties:(172,300)(152,098)(139,931)(107,669)
Net loss available to common stockholders, diluted:(214,124)(217,863)(152,098)(139,931)(107,669)

Comprehensive Income ($ in thousands)

9/30/2023
12/31/2022
TTM
9/30/2022
9/30/2021
9/30/2020
9/30/2019
Net loss:(214,124)(217,863)(152,098)(139,931)(107,669)
Other comprehensive income (loss)(972)(2,389)459(94)94
Comprehensive loss:(215,096)(220,252)(151,639)(140,025)(107,575)
Other undisclosed comprehensive loss, net of tax, attributable to parent (2,468)    
Comprehensive loss, net of tax, attributable to parent:(217,564)(220,252)(151,639)(140,025)(107,575)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: